Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results ...
Havas achieves its 2025 guidance in full and delivers a solid performance, with organic growth1 of 3.1%, and an Adjusted EBIT margin1 of 12.9% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results